Patents Assigned to Ghost Medical Technologies, Ltd
  • Patent number: 9526423
    Abstract: A method for non-contrast enhanced magnetic resonance angiography (“MRA”) that has a short scan time and is insensitive to patient motion is provided. More particularly, the method provides significant arterial conspicuity and substantial venous signal suppression. A two-dimensional single shot acquisition is employed and timed to occur a specific time period after the occurrence of an R-wave in a contemporaneously recorded electrocardiogram. In this manner, k-space data is acquired that is substantially insensitive to variations in arterial flow velocity, or heart rate, and that further substantially suppresses unwanted venous signal in a prescribed imaging slice.
    Type: Grant
    Filed: May 25, 2016
    Date of Patent: December 27, 2016
    Assignee: Ghost Medical Technologies, Ltd.
    Inventor: Robert Edelman
  • Patent number: 9380960
    Abstract: A method for non-contrast enhanced magnetic resonance angiography (“MRA”) that has a short scan time and is insensitive to patient motion is provided. More particularly, the method provides significant arterial conspicuity and substantial venous signal suppression. A two-dimensional single shot acquisition is employed and timed to occur a specific time period after the occurrence of an R-wave in a contemporaneously recorded electrocardiogram. In this manner, k-space data is acquired that is substantially insensitive to variations in arterial flow velocity, or heart rate, and that further substantially suppresses unwanted venous signal in a prescribed imaging slice.
    Type: Grant
    Filed: February 12, 2015
    Date of Patent: July 5, 2016
    Assignee: Ghost Medical Technologies, Ltd
    Inventor: Robert Edelman
  • Patent number: 9211081
    Abstract: A method for non-contrast enhanced magnetic resonance angiography (“MRA”) that has a short scan time and is insensitive to patient motion is provided. More particularly, the method provides significant arterial conspicuity and substantial venous signal suppression. A two-dimensional single shot acquisition is employed and timed to occur a specific time period after the occurrence of an R-wave in a contemporaneously recorded electrocardiogram. In this manner, k-space data is acquired that is substantially insensitive to variations in arterial flow velocity, or heart rate, and that further substantially suppresses unwanted venous signal in a prescribed imaging slice.
    Type: Grant
    Filed: October 7, 2009
    Date of Patent: December 15, 2015
    Assignee: GHOST MEDICAL TECHNOLOGIES, LTD
    Inventor: Robert R. Edelman
  • Patent number: 9176212
    Abstract: A method for non-contrast enhanced magnetic resonance angiography (“MRA”) that has a short scan time and is insensitive to patient motion is provided. More particularly, the method provides significant arterial conspicuity and substantial venous signal suppression. A two-dimensional single shot acquisition is employed and timed to occur a specific time period after the occurrence of an R-wave in a contemporaneously recorded electrocardiogram. In this manner, k-space data is acquired that is substantially insensitive to variations in arterial flow velocity, or heart rate, and that further substantially suppresses unwanted venous signal in a prescribed imaging slice. Alternatively, a two-dimensional multi-shot acquisition is employed to acquire k-space data using an echo train length that is sufficiently short so as to suppress flow-related artifacts, and such that cardiac gating is not required.
    Type: Grant
    Filed: May 31, 2013
    Date of Patent: November 3, 2015
    Assignee: GHOST MEDICAL TECHNOLOGIES, LTD
    Inventor: Robert R. Edelman
  • Patent number: 8332010
    Abstract: A method for non-contrast enhanced magnetic resonance angiography (“MRA”) that has a short scan time and is insensitive to patient motion is provided. More particularly, the method provides significant arterial conspicuity and substantial venous signal suppression. A two-dimensional single shot acquisition is employed and timed to occur a specific time period after the occurrence of an R-wave in a contemporaneously recorded electrocardiogram. In this manner, k-space data is acquired that is substantially insensitive to variations in arterial flow velocity, or heart rate, and that further substantially suppresses unwanted venous signal in a prescribed imaging slice.
    Type: Grant
    Filed: February 14, 2011
    Date of Patent: December 11, 2012
    Assignee: Ghost Medical Technologies, Ltd
    Inventor: Robert R. Edelman